Candriam SCA’s AveXis, Inc. Common Stock AVXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-39,000
Closed -$4.82M 841
2018
Q1
$4.82M Buy
39,000
+10,500
+37% +$1.25M 0.08% 289
2017
Q4
$3.15M Hold
28,500
0.05% 366
2017
Q3
$2.76M Buy
28,500
+3,500
+14% +$316K 0.05% 389
2017
Q2
$2.05M Hold
25,000
0.04% 459
2017
Q1
$1.9M Buy
+25,000
New +$1.55M 0.04% 455
2016
Q4
Sell
-34,000
Closed -$1.4M 702
2016
Q3
$1.4M Sell
34,000
-14,000
-29% -$532K 0.03% 431
2016
Q2
$1.82M Buy
+48,000
New +$1.62M 0.05% 329

Other funds holding AVXS

Candriam SCA's AVXS Position: Q2 2018 in Review

Candriam SCA sold out of AveXis, Inc. Common Stock (AVXS) in Q2 2018, closing a stake of 39,000 shares — an estimated $4.82M sold.

Candriam SCA first reported a position in AVXS in Q2 2016 and held it in 7 quarters. The position peaked at $4.82M in Q1 2018. 1 fund tracked by Wall St. Rank holds AVXS as of Q2 2018.

  • Candriam SCA reported no remaining AveXis, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Candriam SCA sold 39,000 AveXis, Inc. Common Stock shares in Q2 2018, an estimated $4.82M.
  • Candriam SCA first reported a position in AveXis, Inc. Common Stock in Q2 2016 and held it in 7 quarters.
  • Candriam SCA's AveXis, Inc. Common Stock position peaked at $4.82M in Q1 2018.
  • 1 fund tracked by Wall St. Rank held AveXis, Inc. Common Stock as of Q2 2018.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.